Medical Device

SeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2017 and provided guidance for 2018. As quoted in the press release: Revenue of $34.0 million, an increase of 4.5% year-over-year U.S. revenue of $31.2 million, …

SeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2017 and provided guidance for 2018.

As quoted in the press release:

  • Revenue of $34.0 million, an increase of 4.5% year-over-year
  • U.S. revenue of $31.2 million, an increase of 4.8% year-over-year
    º  U.S. Orthobiologics revenue of $16.6 million, an increase of 10.1% year-over-year
    º  U.S. Spinal Implants revenue of $14.6 million, essentially unchanged year-over-year
  • International revenue of $2.8 million, an increase of approximately 1% year-over-year

Click here to read the full press release.

MARKETS

Markets
TSX19062.91+345.79
TSXV647.33+15.54
DOW31500.68+823.32
S&P 5003911.74+116.01
NASD11607.62+375.43
ASX6528.40+19.90

COMMODITIES

Commodities
Gold1827.54+0.47
Silver21.15+0.03
Copper3.740.00
Palladium1879.51+6.50
Platinum911.26+4.32
Oil107.06+2.79
Heating Oil4.24+0.02
Natural Gas6.17-0.07

DOWNLOAD FREE REPORTS

×